Skip to main content
SpringerLink
Log in

Resezierbares hepatozelluläres Karzinom mit Portalvenentumorthrombus

Neoadjuvante RCT verbessert Gesamtüberleben und krankheitsfreies Intervall

  • Journal club
  • Published:
InFo Hämatologie + Onkologie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Wei X et al. J Clin Oncol. 2019;37(24):2141-51

  2. Bettinger D et al. Liver Cancer. 2019;8(4):281-94

  3. European Association for the Study of the Liver et al. J Hepatol. 2018;69(1):182-236

  4. Le Treut YP et al. J Gastrointest Surg. 2006;10(6):855-62

  5. Shi J et al. Ann Surg Oncol. 2010;17(8):2073-80

  6. Korean Liver Cancer Association et al. Gut Liver. 2019;13(3):227-99

  7. Kokudo T et al. J Hepatol. 2016;65(5):938-43

  8. Zhang L et al. Int J Clin Exp Med 2017;10(3):4486-96

  9. Shui Y et al. Radiat Oncol. 2018;13(1):188

  10. Yoon SM et al. JAMA Oncol. 2018;4(5):661-9

  11. Lin H et al. ANZ J Surg. 2018;88(10):E718-E724

Download references

Author information

Authors and Affiliations

  1. Universitätsklinik für Strahlentherapie, Leipziger Str. 44, 39120, Magdeburg, Germany

    Thomas B. Brunner

  2. Universitätsklinik für Allgemein-, Viszeral-, Gefäß- und Transplantationschirurgie, Universitätsklinikum Magdeburg, Magdeburg, Germany

    Roland S. Croner

Authors
  1. Thomas B. Brunner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Roland S. Croner
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Brunner, T., Croner, R. Neoadjuvante RCT verbessert Gesamtüberleben und krankheitsfreies Intervall. InFo Hämatol Onkol 23, 29–31 (2020). https://doi.org/10.1007/s15004-020-8061-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15004-020-8061-0

Search

Navigation